Sunflower Pharmaceutical Group (Tangshan) Bio-Pharm Co., Ltd.

A randomized, open, two-period crossover, single oral trial design was used to compare the differences in absorption extent and absorption rate of ursodeoxycholic acid capsules (specification: 250 mg) provided by Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd. and ursodeoxycholic acid capsules (trade name: Ursofalk®/Ursofalk®; specification: 250 mg) produced by Losan Pharma GmbH (licensed by Dr. Falk Pharma GmbH) in healthy Chinese people under fasting and postprandial administration conditions, and to evaluate the safety of ursodeoxycholic acid capsules (specification: 250 mg) provided by Sunflower Pharmaceutical Group (Tangshan) Biopharmaceutical Co., Ltd.